Data on Chondrosarcoma Detailed by a Researcher at Maria Sklodowska-Curie National Research Institute of Oncology (Mesenchymal Chondrosarcoma from Diagnosis to Clinical Trials).

Předmět:	CLINICAL trials RESEARCH institutes CHONDROSARCOMA RESEARCH personnel DIAGNOSIS ONCOLOGY
Zdroj:	Clinical Trials Week; 10/3/2023, p400-400, 1p
Abstrakt:	According to news originating from Warsaw, Poland, by NewsRx correspondents, research stated, "Mesenchymal chondrosarcoma (MCS) is a rare subtype of chondrosarcoma with a poor prognosis." Keywords: Cancer; Chondrosarcoma; Clinical Research; Clinical Trials and Studies; Diagnostics and Screening; Health and Medicine; Oncology EN Cancer Chondrosarcoma Clinical Research Clinical Trials and Studies Diagnostics and Screening Health and Medicine Oncology 400 400 1 10/03/23 20231003 NES 231003 2023 OCT 2 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Data detailed on chondrosarcoma have been presented. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu